Purchase Order 140D0425P0202
Award Date
9/23/25
Potential Completion Date
2/22/26
Potential Value
$30K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
Interior Business Center
Awardee
Pelago Bioscience AB
Ultimate Awardee
Not listed
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sweden
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $63,800.00 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company, to perform "Small Molecule Target Deconvolution via Cellular Thermal Shift Assay (CETSA)." This requirement was originally posted as a Sources Sought notice, seeking information on qualified sources to perform CETSA experiments, including sample...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....
The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), awarded a $23,940.00 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a View RNA in situ hybridization (ISH) cell assay kit. This acquisition supports NCATS' Cooperative Research and Development Agreement (CRADA) for Alagille syndrome (ALGS) research, specifically to screen compound libraries for activators of the...
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $12,472 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide protein analysis services and equipment. The place of performance is in Potomac, Maryland through October 13, 2023. As part of NIH's efforts to advance translational sciences and support, this award will enable Proteinsimple to...
The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $99,000 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to independently provide services to obtain kinases' percent inhibition for 5,000 data points at one concentration and 400 IC50 curves of malaria compounds. This non-competitive acquisition leverages Life Technologies' specialized expertise in...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,000 firm fixed price purchase order to Enzymlogic SL of Spain. The contract is to provide unspecified services or products in support of NIH NCATS programs from August 2023 through August 2024. No major subcontractors or additional context was provided regarding NCATS's work. The prime contractor will perform all work in Spain under the one-year contract.
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $30,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey for the synthesis of synthetic compounds to support NCATS. Under the terms of the award, Medchemexpress will provide synthetic compound synthesis services to NCATS by November 11, 2022. No set-aside provisions were applied to this procurement. As the lead institute for NIH's translational...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order contract to Emulate, Inc., a for-profit organization, for $361,000.00. The contract is for Emulate's microfluidic-based microphysiological systems (MPS) assay platform to support NCATS' efficacy and toxicity/pharmacokinetics studies during drug discovery and development. The NCATS identified specific technical...